Charles R. Eyler, SEE REMARKS at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 1,239 shares at $22.77 ($28K) on 2018-12-03, disclosed to the SEC on 2018-12-04.
Scheduled sale ($28k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2019-01-04 | $25K | — | Filing → |
| PBYI | SELL | 2018-07-24 | $32K | — | Filing → |
| PBYI | SELL | 2018-06-04 | $64K | — | Filing → |